Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer

European Journal of Surgical Oncology

Volumn 37, Issue 12, 2011, Pages 1064-1071

  Van Heijl, M ^a   Phoa, S S K S ^a   Van Berge Henegouwen, M I ^a   Omloo, J M T ^a   Mearadji, B M ^a   Sloof, G W ^a   Bossuyt, P M M ^a   Hulshof, M C C M ^a   Richel, D J ^a   Bergman, J J G H M ^a   Ten Kate, F J W ^a   Stoker, J ^a   Van Lanschot, J J B ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

3D CT; Chemoradiotherapy; Oesophageal cancer; Response; Volumetry

Indexed keywords

CARBOPLATIN; CONTRAST MEDIUM; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SIZE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; THREE DIMENSIONAL COMPUTED TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; CONTRAST MEDIA; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGING, THREE-DIMENSIONAL; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; ROC CURVE; SAMPLE SIZE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 80955131869     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.09.004     Document Type: Article

References (29)

1. B.L. Brucher, W. Weber, and M. Bauer Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography Ann Surg 233 2001 300 309
2. P. Flamen, E. van Cutsem, and A. Lerut Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer Ann Oncol 13 2002 361 368
3. F. Lordick, K. Ott, and B.J. Krause PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial Lancet Oncol 8 2007 797 805
4. J. Boone, D.P. Livestro, and S.G. Elias International survey on esophageal cancer: part II staging and neoadjuvant therapy Dis Esophagus 22 2009 203 210
5. R.J. Cerfolio, A.S. Bryant, and B. Ohja The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy J Thorac Cardiovasc Surg 129 2005 1232 1241
6. S.G. Swisher, M. Maish, and J.J. Erasmus Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer Ann Thorac Surg 78 2004 1152 1160
7. A.J. Beer, H.A. Wieder, and F. Lordick Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy Radiology 239 2006 472 480
8. M. van Heijl, J.J. van Lanschot, and L.B. Koppert Neoadjuvant ChemoRadiation fOllowed by Surgery versus Surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS) BMC Surg 8 2008 21
9. M. van Heijl, J.M. Omloo, and M.I. van Berge Henegouwen NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial) BMC Med Phys 8 2008 3
10. A.M. Mandard, F. Dalibard, and J.C. Mandard Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 73 1994 2680 2686
11. B.H. Burmeister, B.M. Smithers, and V. Gebski Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol 6 2005 659 668
12. V. Gebski, B. Burmeister, and B.M. Smithers Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 2007 226 234
13. J.F. Bosset, M. Gignoux, and J.P. Triboulet Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 1997 161 167
14. S.G. Urba, M.B. Orringer, and A. Turrisi Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 2001 305 313
15. T.N. Walsh, N. Noonan, and D. Hollywood A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462 467
16. K. Ott, W.A. Weber, and F. Lordick Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction J Clin Oncol 24 2006 4692 4698
17. W.A. Weber, K. Ott, and K. Becker Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging J Clin Oncol 19 2001 3058 3065
18. H.A. Wieder, B.L. Brucher, and F. Zimmermann Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment J Clin Oncol 22 2004 900 908
19. H. Helmberger, U. Baum, and H.J. Dittler Adenocarcinoma of the gastro-esophageal junction: CT for monitoring during neoadjuvant chemotherapy Eur J Radiol 23 1996 107 110
20. H. Hautzel, and H.W. Muller-Gartner Early changes in fluorine-18-FDG uptake during radiotherapy J Nucl Med 38 1997 1384 1386
21. J.F. Griffith, A.C. Chan, and L.T. Chow Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT Br J Radiol 72 1999 678 684
22. T. Nakahara, T. Togawa, and M. Nagata Comparison of barium swallow, CT and thallium-201 SPECT in evaluating responses of patients with esophageal squamous cell carcinoma to preoperative chemoradiotherapy Ann Nucl Med 17 7 2003 583 591
23. M. Westerterp, J.M. Omloo, and G.W. Sloof Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET Int J Hyperthermia 22 2006 149 160
24. C.M. Gillham, J.A. Lucey, and M. Keogan (18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response Br J Cancer 95 2006 1174 1179
25. M. van Heijl, J.M. Omloo, and M.I. van Berge Henegouwen FDG-PET for evaluating response early during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer Ann Surg 253 1 2011 56 63
26. B.M. Smithers, G.C. Couper, and J.M. Thomas Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus Dis Esophagus 21 2 2008 151 158
27. D. Vallböhmer, A.H. Hölscher, and M. Dietlein [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer Ann Surg 250 6 2009 Dec 888 894
28. L.R. Chirieac, S.G. Swisher, and J.A. Ajani Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation Cancer 103 2005 1347 1355
29. P.M. Schneider, S.E. Baldus, and R. Metzger Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification Ann Surg 242 2005 684 692